|
|
|
Antimicrobial Agents and Chemotherapy, September 2004, p . 3284-3290, Vol . 48, No . 9 Functional and Structural Characterization of the Genetic Environment of an Extended-Spectrum ß-Lactamase blaVEB Gene from a Pseudomonas aeruginosa Isolate Obtained in IndiaDaniel Aubert,1 Delphine Girlich,1 Thierry Naas,1 Shanta Nagarajan,2 and Patrice Nordmann1* Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Paris, France,1 Department for Microbiology, Batra Hospital and Medical Research Centre, New Delhi, India2 Received 23 January 2004/ Returned for modification 28 March 2004/ Accepted 20 May 2004
The blaVEB-1 gene was reported first from an Escherichia coli isolate from a Vietnamese patient, in which it was located on a plasmid and an integron (26) . Subsequently, it was detected in two P . aeruginosa isolates from Thailand, in which it was found to be located chromosomally and on an integron (19, 32) . Then, ß-lactamase VEB-1 was identified in a series of gram-negative rods, which underlines its interspecies spread . Several surveys in Thailand and Vietnam emphasized the widespread nature of VEB-1 in Southeast Asia (5, 6, 11, 12, 18) . In addition, VEB-1 had been detected in Kuwait (27) and was recently identified in many Acinetobacter baumannii isolates in France (25) . Four VEB-1-like ß-lactamases that share 99% amino acid identity with VEB-1 have been characterized: VEB-1a (11), VEB-1b (11), VEB-2 (27), and VEB-3 (GenBank accession number AAS48620; X . Jiang, unpublished data) . Compared to VEB-1, VEB-1a has only one amino acid substitution (I18V), which occurs in the leader peptide . The ß-lactamase specific activities determined for E . coli DH10B clones expressing VEB-1 and VEB-1a were similar for the ß-lactams tested (P . Nordmann, unpublished data) . The hydrolytic properties of the other variants have not been studied . We analyzed the ß-lactamase content of a multiresistant P . aeruginosa clinical isolate from India . We report on the identification in India of the VEB-1a ß-lactamase, which had been detected in Kuwait (27), further underlining the spread of blaVEB-1-like genes in Asia . Until now, the blaVEB-1-like genes had always been found to be inserted within the variable regions of class 1 integrons and were mostly associated with the insertion sequence (IS) IS1999 in P . aeruginosa (2) . In the present study, we characterize a blaVEB-1-like gene located in a novel and very peculiar genetic environment made up of repeated DNA sequences . These sequences that drive blaVEB-1-like expression likely represent a novel way for expression of antibiotic resistance genes .
Antimicrobial agents and susceptibility testing. Routine antibiograms were determined by the disk diffusion method on Mueller-Hinton (MH) agar (Sanofi Diagnostics Pasteur) . The antimicrobial agents and their sources have been described elsewhere (17) . The MICs of selected ß-lactams were determined by an agar dilution method on MH plates with a Steers multiple inoculator (31) and an inoculum of 104 CFU/spot . MIC results were interpreted according to NCCLS guidelines (22) . The double-disk synergy test was performed with cefepime and ticarcillin-clavulanic acid disks on MH agar plates . Double-disk tests were also performed on cloxacillin (250 µg/ml)-containing plates to inhibit the activity of the AmpC-type ß-lactamase of P . aeruginosa (10) . Mating-out assay. Conjugation experiments were attempted between isolate P . aeruginosa 10.2 as the donor and rifampin-resistant strains E . coli C600 and P . aeruginosa PU21 as the recipients in liquid and solid media at 37°C . The mating culture was plated onto TS agar plates containing ticarcillin (100 µg/ml) and rifampin (200 µg/ml) . Nucleic acid extractions. Recombinant plasmids were extracted by use of Plasmid Mini-Midi kits (Qiagen, Courtaboeuf, France), whereas natural plasmids were extracted as described by Kieser (15) . Whole-cell DNA from P . aeruginosa 10.2 was extracted as described elsewhere (24) . Total RNAs were extracted with an RNeasy Maxi kit (Qiagen), according to the recommendations of the manufacturer . PCR amplification, cloning experiments, and sequencing. Taq and Pfu DNA polymerases were from Roche Diagnostics (Meylan, France) and Promega Corporation (Madison, Wis.), respectively . Standard PCR amplification experiments (30) were attempted with primers specific for the aadB, arr-2, cmlA5, and aadA1 genes and the genes coding for ß-lactamases OXA-10, TEM, SHV, PER-1, VEB-1, and GES-1, as described previously (12) . The PCR products were purified with Qiaquick columns (Qiagen) . T4 DNA ligase and restriction endonucleases were used according to the recommendations of the manufacturer (Amersham Pharmacia Biotech) . Briefly, the cloning procedure resulted in the ligation of either PstI-, BamHI-, or HindIII-digested whole-cell DNA of P . aeruginosa 10.2 into the PstI-, BamHI-, or HindIII-restricted pBK-CMV vector, respectively . The ligation products were electroporated into E . coli DH10B, and selection was performed on TS agar plates containing amoxicillin (100 µg/ml) and kanamycin (30 µg/ml) . Cloning of repeated element (Re) Re1, associated with the blaVEB-1a gene, was performed as follows: P . aeruginosa 10.2 whole-cell DNA and primer pair Re1F (5'-GCTTTGTCATGTCGACGCGCC-3') and VebcasB (18) were used to amplify a 1.2-kb fragment that was cloned into SmaI-restricted vector pBBR1MCS.3 . The ligation products were electroporated into E . coli DH10B, and selection was performed on TS agar plates containing amoxicillin (100 µg/ml) and tetracycline (30 µg/ml) . One recombinant plasmid, pRe1-Veb, that possessed blaVEB-1a immediately downstream of element Re1 and in the orientation opposite that of Plac was retained for further analysis . Sequencing was performed with laboratory-designed primers on an ABI PRISM 3100 automated sequencer (Applied Biosystems, Les Ullis, France) . Transcription initiation. Reverse transcription and rapid amplification of cDNA ends (RACE) were performed with the 5'RACE system (version 2.0; Invitrogen, Life Technologies, Cergy Pontoise, France) . Five micrograms of total RNA extracted from the culture of P . aeruginosa 10.2 and gene-specific primers blaVEB-1GSP1 (5'-TCAAAGTTGTTCCATTAGGGAATTCC-3'), blaVEB-1GSP2 (5'-GAAAGATTCCCTTTATCTATCTCAGACAA-3'), and blaVEB-1GSP3 (5'-TCAGTTTGAGCATTTGAATACAC-3') were used to determine the blaVEB-1a transcription initiation site . IEF analysis. ß-Lactamase extracts were prepared as described previously (11) and subjected to analytical isoelectric focusing (IEF) on a pH 3.5 to 9.5 ampholine polyacrylamide gel (Amersham Pharmacia Biotech), as described elsewhere (17) . The pI values of the ß-lactamases extracted from P . aeruginosa 10.2 and the E . coli DH10B clones were determined by comparison with those of known ß-lactamases (14) . Kinetic measurements. ß-Lactamase extracts from cultures of E . coli DH10B harboring recombinant plasmid pRe1-Veb, pInt-Veb, or pVeb were prepared as described previously (21) . Enzyme extracts were used for determination of ß-lactamase activity with cefuroxime (a good substrate for measurement of hydrolysis by VEB-1) as the substrate, and kinetic measurements were performed at 30°C in 100 mM Tris-HCl buffer (pH 7) . The initial rates of cefuroxime hydrolysis were determined with an ULTROSPEC 2000 UV spectrophotometer (Amersham Pharmacia Biotech), and total protein contents were measured by the DC protein assay (Bio-Rad), as described previously (26) . Nucleotide sequence accession numbers. The nucleotide sequences of the blaOXA-2a and the blaVEB-1a environments reported in this paper have been submitted to the EMBL/GenBank nucleotide sequence database under accession numbers AY444814 and AY444815, respectively .
Preliminary PCR screening. PCR experiments with primers specific for blaTEM, blaSHV, blaGES-1, and blaPER-1 were negative . A PCR product of 650 bp was obtained by using blaVEB-1-specific internal primers . Sequencing of the PCR product revealed 100% identity with a blaVEB-1-like gene . The blaVEB-1 gene had been described (19) as a gene cassette located within the variable region of class 1 integrons and often associated with the aadB, arr-2 (rifampin resistance marker), cmlA5, blaOXA-10, and aadA1 gene cassettes . No PCR product was obtained by using a series of combinations of primers whose sequences are specific for regions located in class 1 integron structures and the antibiotic resistance genes, suggesting that the genetic environment of blaVEB-1 in P . aeruginosa 10.2 could be different from that of known blaVEB-1-containing integrons . Cloning of ß-lactamase genes. Several E . coli transformants were obtained in each cloning experiment . Disk diffusion antibiograms revealed three distinct ß-lactam resistance profiles . (i) The first phenotype showed resistance to amino-, carboxy-, and ureido-penicillins; restricted- and expanded-spectrum cephalosporins; and aztreonam . A synergy between clavulanic acid and expanded-spectrum cephalosporins suggested the presence of an ESBL that was consistent with the expression of the clavulanate-inhibited VEB-1 ß-lactamase . (ii) The second phenotype showed resistance to amino-, carboxy-, and ureido-penicillins as well as to cephalothin, with a slight synergy between piperacillin and clavulanic acid that indicated the presence of an oxacillinase . (iii) The third phenotype was consistent with expression of a cephalosporinase, since it showed resistance to amoxicillin, amoxicillin-clavulanate, and cephalothin and reduced susceptibility to cefuroxime . The smallest recombinant plasmid for strains expressing each resistance profile was retained for further analysis . The plasmids were designated (i) p10.2-Veb, (ii) p10.2-Oxa, and (iii) p10.2-Ceph and contained a 4.5-kb PstI insert, a 4.6-kb BamHI insert, and a 9.3-kb HindIII insert, respectively . IEF analysis. IEF analysis with E . coli DH10B harboring p10.2-Veb, p10.2-Ceph, and p10.2-Oxa showed that each isolate expressed one ß-lactamase with a pI value of 7.4 (consistent with the presence of VEB-1 [18]), 8.6 (consistent with AmpC from P . aeruginosa [11]), or 8.5 (a third ß-lactamase expressed by p10.2-Oxa [data not shown]) . The same pI values, 7.4, 8.5, and 8.6, were observed with the ß-lactamase extract from P . aeruginosa 10.2 (data not shown) . Genetic locations of ß-lactamase genes. No plasmid DNA was detected in P . aeruginosa 10.2, despite repeated extraction attempts (15) . Transfer of the ß-lactam resistance markers from P . aeruginosa 10.2 to rifampin-resistant E . coli C600 and P . aeruginosa PU21 by mating-out experiments and electroporation of E . coli DH10B cells with the extracted DNA failed . Thus, the genetic support for the locations of the ß-lactamase genes indicated that they are likely chromosomal .
Characterization of blaVEB-1-like gene and its genetic environment.
The sequence of the blaVEB-1-like gene from p10.2-Veb differed by 1 bp from that of the blaVEB-1 gene (26) . This nucleotide substitution led to an amino acid change (I18V) in the putative leader peptide sequence, resulting in the VEB-1a enzyme that had been reported from a P . aeruginosa isolate in Kuwait (27) . Sequence analysis of both sides of the blaVEB-1a gene revealed an atypical genetic environment . Whereas the blaVEB-1a gene was followed by a 59-base element (59-be) that shared 100% nucleotide sequence identity with that previously described for blaVEB-1 gene cassettes (11, 12, 18, 19), it was not preceded by the typical sequence for the recombination core site (Fig . 1) (28) . This blaVEB-1a gene cassette was truncated at its left-hand side just before the cassette-specific ribosomal binding site, which was still present (Fig . 1 and 2A) . Further upstream of blaVEB-1a a qacE
Characterization of other ß-lactamase genes and their genetic environments.
Sequence analysis of inserts of recombinant plasmids p10.2-Oxa, p10.2-Oxa2 (a recombinant plasmid with a 10-kb PstI insert), and p10.2-Ceph was performed . Plasmid p10.2-Oxa2 contained five gene cassettes that were inserted into a class 1 integron named In78 (Fig . 2B): (i) aacA8, which codes for a protein sharing 85% amino acid identity with 6'-N-aminoglycoside acetyltransferase Ib; (ii) blaOXA-2a, which encodes a class D ß-lactamase sharing 99% amino acid identity with OXA-2 (pI 8.5), with the amino acid change occurring in the putative leader peptide sequence (1, 9); (iii) aacA7, which encodes another 6'-N-aminoglycoside acetyltransferase type I; (iv) aadA6, which encodes an aminoglycoside adenylyltransferase (20); and (v) orfD, an ORF of unknown function . At the left hand, the 5'-CS of In78 was bounded by a 25-bp inverted repeat left (IRi) sequence identical to that associated with other integrons (13) . However, the nucleotide sequence flanking IRi was different from those of other known integrons, and no similarity with sequences available in the GenBank database was found . Moreover, the recently identified IS ISpa7 of 1.6 kb was inserted within the 5'-CS region upstream of the integrase gene, as found in In70.2 (GenBank accession number AJ505012; M . L . Riccio, unpublished data) (Fig . 2B), indicating a possible spread of the ISpa7 sequence in P . aeruginosa . The 3'-CS of In78 contained a truncated tni module with no ISs in the 3'-CS-tniB Finally, plasmid p10.2-Ceph contained a 1.2-kb ORF coding for a ß-lactamase that shared 98% amino acid sequence identity with the naturally occurring AmpC-type cephalosporinase from P . aeruginosa reference strain PAO1 . Control of blaVEB-1a gene expression. blaVEB-1 gene expression in P . aeruginosa has been shown to be driven either by the Pant promoter, located in the 5'-CS, or by the Pant promoter together with the Pout promoter located on IS1999 (2); IS1999 is mostly located upstream of blaVEB-1 in P . aeruginosa . The lack of a 5'-CS region upstream of blaVEB-1a in P . aeruginosa 10.2 and the lack of IS1999 raised the question of the means by which blaVEB-1a is expressed . In order to determine whether the Res were capable of driving blaVEB-1a gene expression, recombinant plasmid pRe1-Veb was constructed (Fig . 2C) . Measurement of the specific ß-lactamase activities of culture extracts of E . coli DH10B(pRe1-Veb) indicated that Re1 likely contained a promoter responsible for blaVEB-1a gene expression . Comparison of the specific activities of the ß-lactamase extracts from E . coli DH10B(pRe1-Veb) and E . coli DH10B(pInt-Veb) (Fig . 2C) (2) showed that the Re1 promoter was threefold stronger than the Pant promoter (35 [TGGACA] and 10 [TAAGCT]) located in the 5'-CSs of class 1 integrons (Fig . 2C) . In contrast, pVeb (Fig . 2C) (2), which lacks any promoter sequence, did not provide detectable ß-lactamase activity, suggesting that the activities measured with pRe1-Veb were not the result of the activities of nonspecific promoters located somewhere in the cloning vector . The strength of the Re1 promoter and its in vivo effect were confirmed by the MIC results . Indeed, the MICs of most ß-lactams for E . coli DH10B(pRe1-Veb) were two- to threefold higher than those for E . coli DH10B(pInt-Veb) (Table 1) . By using 5'RACE, PRe1, the promoter located on Re1, was precisely mapped in P . aeruginosa 10.2 . Transcription initiation occurred at a thymidine (nucleotide position 405; Fig . 1) . Upstream of base pair 405, a 35 promoter region (TTTTCA) separated by 18 bp from a 10 promoter region (TAAGAT) was found . This promoter sequence is also present in the first Re1 and Re3, whereas Re2 contained a related sequence (Fig . 2A and 3) . It is likely that a second PRe1 located in the other Re1 sequence may also contribute to blaVEB-1a gene expression in P . aeruginosa 10.2; however it was not evidenced under our experimental conditions with 5'RACE (data not shown) . Conclusion. This is the first report describing a blaVEB-1-like gene in a P . aeruginosa clinical isolate from the Indian subcontinent and thus further underlined its spread in Asia . In addition, this report indicated that a blaVEB-1-like gene may be located outside a class 1 integron structure . From a more general point of view, this work indicated that integrons may also constitute a reservoir for the spread of antibiotic resistance genes that may be located and expressed either inside or outside an integron structure . The presence of four 135-bp Re sequences surrounding this blaVEB-1a gene was very peculiar . The question of the origins of these Res and their functions in the mobilization of blaVEB-1a remain to be determined . These sequences might play a role in homologous recombination events . Finally, we have shown that these sequences carry active promoters for blaVEB-1a gene expression, which also seems to be a novel feature for expression of antibiotic resistance genes .
What Is Dna?,
What Is Botulism?,
What Is Cell Biology?,
What Is Bioengineering?,
What Is Molecular Biology?,
n,
Microbes,
e,
Microorganism,
e,
Microbiology,
n,
Bacteria,
c,
Microbe,
n,
Pasteurella,
i,
Bacillus anthracis,
n,
Salmonella typhimurium,
s,
Haemophilus,
n,
Escherichia coli,
i,
Streptococci,
a,
Clostridia,
o,
Microorganism,
e,
Lactobacillus,
c,
Cell cultures,
r,
Clostridia,
c,
Biological filters,
a,
Clostridia,
e,
Bacillus subtilis,
a,
Pseudomonas aeruginosa,
o,
Sepsis,
i,
Growth media,
e,
Enterobacters,
c,
Pathogenic bacterium,
c,
Streptococci,
n,
Cell suspensions
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||